ZBP1 and neoplasm: GEGFR, CD40, SPATA2, ZBP1, ID1, and MYC showed a significant CNV amplification in most tumour types; however, TLR3, PDHB, FAS, and MAP3K showed a significant CNV deletion in most tumour types.